Quarterly report · Q1
8086.TEDINET S100OZ7P
Period2022-04-01 → 2022-06-30
Filed2022-08-12
StandardJapan GAAP
ConsolidatedYes
Data checks12 of 12 passed
Key figures · 33
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥127.9bn | 2022-04-01 → 2022-06-30 | Cons. | Net sales |
| Revenue | ¥494.8bn | 2021-04-01 → 2022-03-31 | Cons. | Net sales (5-year summary) |
| Revenue | ¥118.0bn | 2021-04-01 → 2021-06-30 | Cons. | Net sales |
| Operating income | ¥3.0bn | 2022-04-01 → 2022-06-30 | Cons. | Operating income |
| Operating income | ¥5.5bn | 2021-04-01 → 2021-06-30 | Cons. | Operating income |
| Ordinary income | ¥7.3bn | 2022-04-01 → 2022-06-30 | Cons. | Ordinary income |
| Ordinary income | ¥27.6bn | 2021-04-01 → 2022-03-31 | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥5.2bn | 2021-04-01 → 2021-06-30 | Cons. | Ordinary income |
| Profit before tax | ¥9.0bn | 2022-04-01 → 2022-06-30 | Cons. | Income before income taxes |
| Profit before tax | ¥5.3bn | 2021-04-01 → 2021-06-30 | Cons. | Income before income taxes |
| Net income (owners) | ¥5.3bn | 2022-04-01 → 2022-06-30 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥13.5bn | 2021-04-01 → 2022-03-31 | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥3.3bn | 2021-04-01 → 2021-06-30 | Cons. | Profit loss attributable to owners of parent |
| Net income | ¥5.7bn | 2022-04-01 → 2022-06-30 | Cons. | Profit loss |
| Net income | ¥3.5bn | 2021-04-01 → 2021-06-30 | Cons. | Profit loss |
| Total assets | ¥947.6bn | at 2022-06-30 | Cons. | Assets |
| Total assets | ¥930.3bn | at 2022-03-31 | Cons. | Assets |
| Total assets | ¥874.8bn | at 2021-06-30 | Cons. | Total assets (5-year summary) |
| Total liabilities | ¥730.3bn | at 2022-06-30 | Cons. | Liabilities |
| Total liabilities | ¥730.5bn | at 2022-03-31 | Cons. | Liabilities |
| Net assets / equity | ¥217.3bn | at 2022-06-30 | Cons. | Net assets |
| Net assets / equity | ¥199.9bn | at 2022-03-31 | Cons. | Net assets |
| Net assets / equity | ¥185.9bn | at 2021-06-30 | Cons. | Net assets (5-year summary) |
| Cash and deposits | ¥84.7bn | at 2022-06-30 | Cons. | Cash and deposits |
| Cash and deposits | ¥95.3bn | at 2022-03-31 | Cons. | Cash and deposits |
| EPS (basic) | ¥32.35 | 2022-04-01 → 2022-06-30 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥82.5 | 2021-04-01 → 2022-03-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥20.24 | 2021-04-01 → 2021-06-30 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (diluted) | ¥28.66 | 2022-04-01 → 2022-06-30 | Cons. | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥77.42 | 2021-04-01 → 2022-03-31 | Cons. | Diluted earnings per share (5-year summary) |
| Equity ratio | 21.3% | at 2022-06-30 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 19.9% | at 2022-03-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 19.8% | at 2021-06-30 | Cons. | Equity to asset ratio (5-year summary) |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 54
| Segment | Item | Period | Value |
|---|---|---|---|
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue | 2022-04-01 → 2022-06-30 | ¥1.0bn |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue external | 2022-04-01 → 2022-06-30 | ¥154m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue intersegment | 2022-04-01 → 2022-06-30 | ¥855m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | segment profit | 2022-04-01 → 2022-06-30 | ¥211m |
| Reconciling Itemsreconciling | revenue | 2022-04-01 → 2022-06-30 | −¥9.3bn |
| Reconciling Itemsreconciling | revenue intersegment | 2022-04-01 → 2022-06-30 | −¥9.3bn |
| Reconciling Itemsreconciling | segment profit | 2022-04-01 → 2022-06-30 | −¥7.1bn |
| jpcrp040300-q1r_E02688-000Medical Treatment Relatedreportable segment | revenue | 2022-04-01 → 2022-06-30 | ¥99.3bn |
| jpcrp040300-q1r_E02688-000Medical Treatment Relatedreportable segment | revenue external | 2022-04-01 → 2022-06-30 | ¥97.7bn |
| jpcrp040300-q1r_E02688-000Medical Treatment Relatedreportable segment | revenue intersegment | 2022-04-01 → 2022-06-30 | ¥1.6bn |
| jpcrp040300-q1r_E02688-000Medical Treatment Relatedreportable segment | segment profit | 2022-04-01 → 2022-06-30 | ¥8.5bn |
| jpcrp040300-q1r_E02688-000Medicine Relatedreportable segment | revenue | 2022-04-01 → 2022-06-30 | ¥23.2bn |
| jpcrp040300-q1r_E02688-000Medicine Relatedreportable segment | revenue external | 2022-04-01 → 2022-06-30 | ¥17.9bn |
| jpcrp040300-q1r_E02688-000Medicine Relatedreportable segment | revenue intersegment | 2022-04-01 → 2022-06-30 | ¥5.3bn |
| jpcrp040300-q1r_E02688-000Medicine Relatedreportable segment | segment profit | 2022-04-01 → 2022-06-30 | ¥407m |
| jpcrp040300-q1r_E02688-000Pharma Packagingreportable segment | revenue | 2022-04-01 → 2022-06-30 | ¥13.7bn |
| jpcrp040300-q1r_E02688-000Pharma Packagingreportable segment | revenue external | 2022-04-01 → 2022-06-30 | ¥12.2bn |
| jpcrp040300-q1r_E02688-000Pharma Packagingreportable segment | revenue intersegment | 2022-04-01 → 2022-06-30 | ¥1.5bn |
| jpcrp040300-q1r_E02688-000Pharma Packagingreportable segment | segment profit | 2022-04-01 → 2022-06-30 | ¥1.0bn |
| —segment total | revenue | 2022-04-01 → 2022-06-30 | ¥136.2bn |
| —segment total | revenue external | 2022-04-01 → 2022-06-30 | ¥127.7bn |
| —segment total | revenue intersegment | 2022-04-01 → 2022-06-30 | ¥8.4bn |
| —segment total | segment profit | 2022-04-01 → 2022-06-30 | ¥9.9bn |
| Total Of Reportable Segments And Otherssegment total | revenue | 2022-04-01 → 2022-06-30 | ¥137.2bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2022-04-01 → 2022-06-30 | ¥127.9bn |
| Total Of Reportable Segments And Otherssegment total | revenue intersegment | 2022-04-01 → 2022-06-30 | ¥9.3bn |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2022-04-01 → 2022-06-30 | ¥10.1bn |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue | 2021-04-01 → 2021-06-30 | ¥693m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue external | 2021-04-01 → 2021-06-30 | ¥153m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue intersegment | 2021-04-01 → 2021-06-30 | ¥540m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | segment profit | 2021-04-01 → 2021-06-30 | ¥145m |
| Reconciling Itemsreconciling | revenue | 2021-04-01 → 2021-06-30 | −¥8.8bn |
| Reconciling Itemsreconciling | revenue intersegment | 2021-04-01 → 2021-06-30 | −¥8.8bn |
| Reconciling Itemsreconciling | segment profit | 2021-04-01 → 2021-06-30 | −¥5.6bn |
| jpcrp040300-q1r_E02688-000Medical Treatment Relatedreportable segment | revenue | 2021-04-01 → 2021-06-30 | ¥92.2bn |
| jpcrp040300-q1r_E02688-000Medical Treatment Relatedreportable segment | revenue external | 2021-04-01 → 2021-06-30 | ¥90.6bn |
| jpcrp040300-q1r_E02688-000Medical Treatment Relatedreportable segment | revenue intersegment | 2021-04-01 → 2021-06-30 | ¥1.5bn |
| jpcrp040300-q1r_E02688-000Medical Treatment Relatedreportable segment | segment profit | 2021-04-01 → 2021-06-30 | ¥9.5bn |
| jpcrp040300-q1r_E02688-000Medicine Relatedreportable segment | revenue | 2021-04-01 → 2021-06-30 | ¥21.5bn |
| jpcrp040300-q1r_E02688-000Medicine Relatedreportable segment | revenue external | 2021-04-01 → 2021-06-30 | ¥16.4bn |
| jpcrp040300-q1r_E02688-000Medicine Relatedreportable segment | revenue intersegment | 2021-04-01 → 2021-06-30 | ¥5.1bn |
| jpcrp040300-q1r_E02688-000Medicine Relatedreportable segment | segment profit | 2021-04-01 → 2021-06-30 | ¥587m |
| jpcrp040300-q1r_E02688-000Pharma Packagingreportable segment | revenue | 2021-04-01 → 2021-06-30 | ¥12.4bn |
| jpcrp040300-q1r_E02688-000Pharma Packagingreportable segment | revenue external | 2021-04-01 → 2021-06-30 | ¥10.8bn |
| jpcrp040300-q1r_E02688-000Pharma Packagingreportable segment | revenue intersegment | 2021-04-01 → 2021-06-30 | ¥1.6bn |
| jpcrp040300-q1r_E02688-000Pharma Packagingreportable segment | segment profit | 2021-04-01 → 2021-06-30 | ¥844m |
| —segment total | revenue | 2021-04-01 → 2021-06-30 | ¥126.1bn |
| —segment total | revenue external | 2021-04-01 → 2021-06-30 | ¥117.8bn |
| —segment total | revenue intersegment | 2021-04-01 → 2021-06-30 | ¥8.2bn |
| —segment total | segment profit | 2021-04-01 → 2021-06-30 | ¥10.9bn |
| Total Of Reportable Segments And Otherssegment total | revenue | 2021-04-01 → 2021-06-30 | ¥126.8bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2021-04-01 → 2021-06-30 | ¥118.0bn |
| Total Of Reportable Segments And Otherssegment total | revenue intersegment | 2021-04-01 → 2021-06-30 | ¥8.8bn |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2021-04-01 → 2021-06-30 | ¥11.1bn |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 442
| Item | Context | Value | Unit |
|---|---|---|---|
| Operating income | CurrentYTDDuration | 2954000000 | JPY |
| Document title cover page | FilingDateInstant | Original text (Japanese)四半期報告書 | |
| Clause of stipulation cover page | FilingDateInstant | Original text (Japanese)金融商品取引法第24条の４の７第１項 | |
| Place of filing cover page | FilingDateInstant | Original text (Japanese)関東財務局長 | |
| Filing date cover page | FilingDateInstant | 2022-08-12 | |
| Quarterly accounting period cover page | FilingDateInstant | Original text (Japanese)第70期第１四半期(自 2022年４月１日 至 2022年６月30日) | |
| Company name cover page | FilingDateInstant | Original text (Japanese)ニプロ株式会社 | |
| Company name in english cover page | FilingDateInstant | NIPRO CORPORATION | |
| Title and name of representative cover page | FilingDateInstant | Original text (Japanese)代表取締役社長 佐 野 嘉 彦 | |
| Address of registered headquarter cover page | FilingDateInstant | Original text (Japanese)大阪市北区本庄西３丁目９番３号 | |
| Telephone number address of registered headquarter cover page | FilingDateInstant | Original text (Japanese)大阪06(6372)2331(代表) | |
| Name of contact person address of registered headquarter cover page | FilingDateInstant | Original text (Japanese)常務取締役経営企画本部長 余 語 岳 仁 | |
| Nearest place of contact cover page | FilingDateInstant | Original text (Japanese)大阪市北区本庄西３丁目９番３号 | |
| Telephone number nearest place of contact cover page | FilingDateInstant | Original text (Japanese)大阪06(6372)2331(代表) | |
| Name of contact person nearest place of contact cover page | FilingDateInstant | Original text (Japanese)常務取締役経営企画本部長 余 語 岳 仁 | |
| Place for public inspection cover page (text) | FilingDateInstant | Text · Plus | |
| Edinet code | FilingDateInstant | E02688 | |
| Fund code | FilingDateInstant | － | |
| Security code | FilingDateInstant | 80860 | |
| Filer name in japanese | FilingDateInstant | Original text (Japanese)ニプロ株式会社 | |
| Filer name in english | FilingDateInstant | NIPRO CORPORATION | |
| Fund name in japanese | FilingDateInstant | － | |
| Fund name in english | FilingDateInstant | － | |
| Cabinet office ordinance | FilingDateInstant | Original text (Japanese)企業内容等の開示に関する内閣府令 | |
| Document type | FilingDateInstant | Original text (Japanese)第四号の三様式 | |
| Accounting standards | FilingDateInstant | Japan GAAP | |
| Whether consolidated financial statements are prepared | FilingDateInstant | true | |
| Industry code when consolidated financial statements are prepared in accordance with industry specific regulations | FilingDateInstant | cte | |
| Industry code when financial statements are prepared in accordance with industry specific regulations | FilingDateInstant | － | |
| Current fiscal year start date | FilingDateInstant | 2022-04-01 | |
| Current period end date | FilingDateInstant | 2022-06-30 | |
| Type of current period | FilingDateInstant | Q1 | |
| Current fiscal year end date | FilingDateInstant | 2023-03-31 | |
| Previous fiscal year start date | FilingDateInstant | 2021-04-01 | |
| Comparative period end date | FilingDateInstant | 2021-06-30 | |
| Previous fiscal year end date | FilingDateInstant | 2022-03-31 | |
| Next fiscal year start date | FilingDateInstant | － | |
| End date of quarterly or semi annual period of next fiscal year | FilingDateInstant | － | |
| Amendment flag | FilingDateInstant | false | |
| Identification of document subject to amendment | FilingDateInstant | － | |
| Report amendment flag | FilingDateInstant | false | |
| Xbrl amendment flag | FilingDateInstant | false | |
| Business results of group (text) | FilingDateInstant | Text · Plus | |
| Description of business (text) | FilingDateInstant | Text · Plus | |
| Business risks (text) | FilingDateInstant | Text · Plus | |
| Management analysis of financial position operating results and cash flows (text) | FilingDateInstant | Text · Plus | |
| Critical contracts for operation (text) | FilingDateInstant | Text · Plus | |
| Total number of shares (text) | FilingDateInstant | Text · Plus | |
| Issued shares total number of shares etc (text) | FilingDateInstant | Text · Plus | |
| Class issued shares total number of shares etc | FilingDateInstant_OrdinaryShareMember | Original text (Japanese)普通株式 |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 12 of 12 passed
| balance sheet identity | pass rounding |
| balance sheet identity | pass |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |